Discover 2,012 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,012
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Boston MA, Philadelphia PA, Fairfax VA, Jacksonville FL,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06720987
Phase1, Recruiting
BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence
for
Stress Urinary Incontinence
Location: Royal Oak MI
Sponsor: Corewell Health East
Sex: All
Age: 18 - 70+
Code: NCT04133675
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
for
Schizophrenia
Location: Boston MA, Watertown MA, The Bronx NY, New York NY,
Sponsor: MapLight Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07459647
Phase2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
for
Clostridium Difficile Infection
Location: Grand Rapids MI
Sponsor: Spectrum Health Hospitals
Sex: All
Age: 18+
Code: NCT02237859
Recruiting
Patient Retrospective Outcomes (PRO)
for
Chronic Pain
Location: The Bronx NY, New Bern NC, Jupiter FL, Vero Beach FL,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT01550575
Recruiting
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
for
Biliary Tract Cancer
Location: New York NY, Montreal, Richmond VA, Toronto, Orlando FL,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06282575
Phase3, Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: St. John's, Halifax, Moncton, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
for
Neoplasm, Cancer, Malignant Tumors
Location: Boston MA, New Haven CT, Fairfax VA, Grand Rapids MI,
Sponsor: Compugen Ltd
Sex: All
Age: 18+
Code: NCT06759649
Phase1, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: New Haven CT, Montreal, Baltimore MD, Durham NC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase3, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase2, Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Providence RI, Lebanon NH, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase3, Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis, Ulcerative Colitis Chronic
Location: Hamden CT, Jackson Heights NY, Brooklyn NY, Utica NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06598943
Phase2, Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: New Brunswick NJ, Greenville NC, Wilmington NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07415044
Phase2, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Boston MA, Lake Success NY, New Hyde Park NY,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase2, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Providence RI, New Haven CT, Quebec, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Boston MA, Milford CT, New York NY, Philadelphia PA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase3, Recruiting
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
for
Cardiac Failure, Graft Rejection
Location: New York NY, Pittsburgh PA, Ann Arbor MI, Nashville TN,